Webdisclosure.com

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

04/07/2022 07:15

Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

04/07/2022 07:00

Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

21/06/2022 14:30

Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

17/06/2022 07:00

Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

13/06/2022 07:00

Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

08/06/2022 07:00

Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

01/06/2022 07:00

Relief Therapeutics Announces Results of Annual General Meeting of RELIEF THERAPEUTICS Holding SA

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

31/05/2022 07:00

Relief Provides a Corporate Update and Comments on the Recently Announced DSMB Update on the U.S. National Institutes of Health (NIH) Study of Intravenous Aviptadil in Critical COVID-19 Patients

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

26/05/2022 13:00

Relief Reports that its U.S. Collaboration Partner Announces Data Safety Monitoring Board (DSMB) Update on the U.S. National Institutes of Health (NIH) Study of aviptadil in Critical COVID-19

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

23/05/2022 06:55

Relief Therapeutics Expands U.S. Commercial Team

Voir tous les communiqués de Relief Therapeutics Holdings AG

«
1
2
3
4
5
6
7
8
9
10